[1]王江静,刘国强,潘浩,等.基于生物信息学方法探讨骨质疏松症不同病因病机的治疗要点[J].西部中医药,2024,37(07):50-54.[doi:10.12174/j.issn.2096-9600.2024.07.13]
　WANG Jiangjing,LIU Guoqiang,PAN Hao,et al.The Treatment Points for Osteoporosis with Different Causes and Pathogenesis Based on Bioinformatics Methods[J].Western Journal of Traditional Chinese Medicine,2024,37(07):50-54.[doi:10.12174/j.issn.2096-9600.2024.07.13]
点击复制

基于生物信息学方法探讨骨质疏松症不同病因病机的治疗要点
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年07期
页码:
50-54
栏目:
二次研究
出版日期:
2024-07-15

文章信息/Info

Title:
The Treatment Points for Osteoporosis with Different Causes and Pathogenesis Based on Bioinformatics Methods
作者:
王江静, 刘国强, 潘浩, 季文辉
河北省沧州中西医结合医院，河北 沧州 061000
Author(s):
WANG Jiangjing, LIU Guoqiang, PAN Hao, JI Wenhui
Cangzhou Hospital of Integrated TCM-WM, Cangzhou 061000, China
关键词:
骨质疏松症; 病因病机; GEO数据库; 网络药理学; 中医中药
Keywords:
osteoporosis; the cause and pathogenesis; GEO database; network pharmacology; TCM and materia medica
分类号:
R274.9
DOI:
10.12174/j.issn.2096-9600.2024.07.13
文献标志码:
A
摘要:
目的探讨在生物信息学方法指导下骨质疏松症（osteoporosis，OP）不同病因病机的治疗要点。 方法以滋补肝肾、益气健脾、活血化瘀代表药物为搜索词，在中药系统药理数据库检索活性成分及预测靶点，借助Cytoscape 3.7.2软件构建药物与靶点之间的网络图。通过基因表达数据库（gene expression omnibus database，GEO）相关芯片分析差异基因，结合疾病数据库获取OP所有疾病靶点并构建药物与疾病的关键靶点韦恩图。通过DAVID数据库对关键靶点进行基因本体及京都基因与基因组百科全书富集，以探讨不同病因病机下OP的防治要点。 结果滋补肝肾、益气健脾及活血化瘀组分别筛选出146个、126个及117个靶点，GEO数据库筛选出1173个差异基因，疾病数据库筛选出靶点336个，去重整合后共获得OP靶点1469个。滋补肝肾、益气健脾组映射出25个相同靶点，活血化瘀组映射出21个关键靶点。基因可视化分析发现肝肾亏虚及脾胃虚弱型OP的治疗要点，且主要集中在肿瘤坏死因子通路、核苷酸结合寡聚化结构域样受体通路等方面；气血瘀阻型的治疗要点主要在血管内皮生长因子通路、缺氧诱导因子1通路等方面。 结论OP具有复杂的病因病机，在对症治疗时，肝肾亏虚及脾胃虚弱型更应注重控制体内炎症水平，气血瘀阻型更应注意体内局部血管构建及纠正缺氧状态。同时，众多病因病机之间存在着相似病理过程，也应注重全面调控及防治。
Abstract:
ObjectiveTo discuss the treatment points for osteoporosis with different causes and patho-genesis based on bioinformatics methods. MethodsThe representative drugs of nourishing liver and kidney, benefitting Qi and invigorating spleen, activating blood and removing stasis were chosen as the key words to search the active ingredients and the predicted targets from the traditional Chinese medicine systems pharma-cology database and analysis platform (TCMSP), to construct the network diagram between drug and targets via Cytoscape 3.7.2 software. The differential genes were analyzed via gene expression omnibus database (GEO) associated microarrays, combined with disease database, all the disease targets of osteoporosis were obtained, and venny diagram of key targets of drugs and disease was constructed. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) of the key targets were performed using DAVID databases, to discuss the treatment points of osteoporosis with different causes and pathogenesis. ResultsAll 146 targets, 126 ones and 117 ones were screened in the groups of nourishing liver and kidney, benefitting Qi and invigorating spleen, activating blood and removing stasis respectively, 1173 differential genes were screened from GEO database, 336 targets were screened from disease database, after de-reintegration, all 1469 osteoporosis-related targets were gained. The groups of nourishing liver and kidney, benefitting Qi and invigorating spleen mapped 25 common targets, the group of activating blood and removing stasis mapped 21 key targets. Genetic visualization analysis showed that the main therapeutic points of osteoporosis of liver and kidney depletion pattern, spleen-stomach weakness pattern lie in tumor necrosis factor pathway, nucleotide-binding oligomerisation structural domain-like receptor pathway, etc; the main therapeutic points of osteoporosis of Qi and blood stagnation pattern mainly focus on vascular endothelial growth factor pathway and hypoxia-inducible factor-1 pathway. ConclusionOsteoporosis has a complicated etiology and pathogenesis. In symptomatic treatment, we should pay attention to the regulation of the level of inflammation in the patients with osteoporosis of liver and kidney depletion pattern, spleen-stomach weakness pattern, and focus on the construction of local vessels and the correction of hypoxic state in the patients of Qi and blood stagnation pattern. Meanwhile we should focus on the complete regulation, the prevention and the treatment, as there are similar pathological processes among many causes and pathogenesis.

相似文献/References:

[1]李翼哲,李庆兵,吉海春,等.“寒”在大骨节病病因病机中的作用[J].西部中医药,2011,24(11):16.
[2]潘文,王贵霞,王晓萍.多囊卵巢综合征伴胰岛素抵抗的发病机制研究及中药干预作用[J].西部中医药,2012,25(12):121.
　PAN Wen,WANG Gui-xia,WANG Xiao-ping.Study on Pathogenesis of Polycystic Ovary Syndrome Complicated with Insulin Resistance and Intervention with Traditional Chinese Medicine[J].Western Journal of Traditional Chinese Medicine,2012,25(07):121.
[3]汝亚琴,金智生.中医药治疗年龄相关性黄斑变性研究进展[J].西部中医药,2013,26(09):141.
　RU Yaqin,JIN Zhisheng.Research Progress on TCM Treating Age-related Macular Degeneration[J].Western Journal of Traditional Chinese Medicine,2013,26(07):141.
[4]黄清杰,李茂星,刘 雄△.中医治疗药物性肝损伤研究进展[J].西部中医药,2012,25(07):124.
　HUANG Qing-jie,LI Mao-xing,LIU Xiong.Progress of Study on Treatment of Drug-induced Liver Injury with TCM[J].Western Journal of Traditional Chinese Medicine,2012,25(07):124.
[5]谢栋,陈大军,马国亮,等.原发性骨质疏松症的骨密度与中医脏腑辨证的相关性研究*[J].西部中医药,2015,28(02):82.
[6]梁敏.绝经后骨质疏松症42例护理体会[J].西部中医药,2015,28(12):129.
[7]高世东.从肝脾肾论治高脂血症[J].西部中医药,2013,26(06):18.
　GAO Shidong.On Hyperlipoidemia Treated from Liver, Spleen and Kidney[J].Western Journal of Traditional Chinese Medicine,2013,26(07):18.
[8]张彩凤,程卫东△,王彩霞,等.玫参胶囊治疗围绝经期骨质疏松症60例[J].西部中医药,2012,25(05):16.
　ZHANG Cai-feng,CHENG Wei-dong,WANG Cai-xia,et al.MeiShen Capsule in Treating 60 Cases of Menopausal Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2012,25(07):16.
[9]刘晓燕,王四兵,程秋实,等.中医药治疗慢性萎缩性胃炎临床研究进展[J].西部中医药,2013,26(12):147.
　LIU Xiaoyan,WANG Sibin,CHENG Qiushi,et al.Clinical Study Progress of TCM in Treating Chronic Atrophic Gastritis[J].Western Journal of Traditional Chinese Medicine,2013,26(07):147.
[10]王红玉.大学生失眠的中医辨治[J].西部中医药,2013,26(05):75.
　WANG hongyu.Syndrome Differentiation for Insomnia of University Students[J].Western Journal of Traditional Chinese Medicine,2013,26(07):75.
[11]张德宏,李晶.老年骨质疏松症的病因病机及防治原则探析[J].西部中医药,2013,26(03):90.
　ZHANG Dehong,LI Jing.The Etiology, Pathogenesis and Prevention Principles of Senile Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2013,26(07):90.

备注/Memo

备注/Memo:
王江静（1981—），女，硕士学位，副主任医师。研究方向：骨与关节运动损伤的诊治。Email：wjjlunwen@163.com。国家自然科学基金（81873310）。 河北省医学科学研究重点课题计划项目（20160397）；河北省中医药科研计划项目（2020505）。
更新日期/Last Update: 2024-07-15